Description

3-Phenyl-5,6,7,8-Tetrahydro-Imidazo[1,2-A]Pyrazine Dihydrochloride is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in central nervous system (CNS) and oncology research. It is primarily required by pharmaceutical R&D laboratories, contract research and manufacturing organizations (CROs/CMOs), and fine chemical suppliers engaged in the development of new therapeutic agents.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel drug candidates, especially those targeting neurological disorders.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• API Development: Used in the development and scale-up processes for new Active Pharmaceutical Ingredients (APIs) requiring the imidazopyrazine core.
• Biochemical Tool Compound: Potential use in biochemical assays and as a probe for studying specific biological pathways and enzyme interactions.
• Contract Manufacturing: Supplied to CMOs for the cGMP production of clinical trial materials and commercial APIs.
• Academic Research: Utilized in university and institutional labs for advanced organic synthesis and pharmacological studies.

Basic Information

Product Name	3-Phenyl-5,6,7,8-Tetrahydro-Imidazo[1,2-A]Pyrazine Dihydrochloride
CAS No.	1986429-23-5
Molecular Formula	C₁₃H₁₆Cl₂N₄
Molecular Weight	299.20 g/mol
Synonyms	3-Phenyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine dihydrochloride; Imidazo[1,2-a]pyrazine, 3-phenyl-5,6,7,8-tetrahydro-, dihydrochloride; 3-Phenyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride (1:2); 1986429-23-5; UNII-9V1I4H73Z2; 9V1I4H73Z2; AKOS040759186; BDBM50389375; ZINC000253949996
EINECS	Contact for details

Quality Control

Our 3-Phenyl-5,6,7,8-Tetrahydro-Imidazo[1,2-A]Pyrazine Dihydrochloride is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the stringent requirements for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccated conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.